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Introduction. Gonorrhea is one of the most common sexually 
transmitted infections (STIs) in developing countries, and the 
emergence of resistance to antimicrobial agents in Neisseria gon-
orrhoeae is a major obstacle in the control of gonorrhoea. Peri-
odical determination of the prevalence and monitoring of antimi-
crobial susceptibility of N. gonorrhoeae is essential for the early 
detection of emergence of drug resistance. 
Methods. A total of 640 consecutive patients who attended the 
Outpatient Department (OPD) Clinics at St. Mary’s Hospital 
Lacor between Jan 2007-Dec 2011, with gonococcal urethri-
tis symptoms and whose urethral swabs and high vagina swabs 
(HVS) were cultured, were involved in the study. Two hundred 
and fifty six (256) patients had positive pus swab culture, of which 
151 (23.6%) showed growth of Neisseria gonorrhoeae. All the 
isolates were tested for antimicrobial susceptibility using the 
Kirby Bauer-Disc diffusion techniques.
Results. Gonococcal isolates showed rapid decrease in suscepti-
bility to the antimicrobials especially to Ampicillin, Tetracycline 
and Erythomycin, Ciprofloxacin, and intermediate to chloram-
phenicol, however, Gentamicin and cefotaxime have remained as 
a single dose sensitive treatment for Neisseria gonorrhoeae. Sen-
sitization on drug use and adopting preventive measures and con-
tinuous education on safer sexual behavior through health care 
authorities would lead to reduction in the prevalence of Neisseria 
gonorrhoeae and resistance to antimicrobial.
Discussion. Gonorrhea is one of the most common sexually trans-
mitted infections (STIs) in developing countries, and the emer-
gence of resistance to antimicrobial agents in Neisseria gonor-
rhoeae is a major obstacle in the control of gonorrhea. Periodi-
cal monitoring of antimicrobial susceptibility of N. gonorrhea is 
essential for the early detection of emergence of drug resistance.
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Summary
Introduction
Gonorrhoea is one of the classical sexually transmitted 
infections (STIs) with human as the only host for the 
causative agent Neisseria gonorrhoeae and since an-
cient times it continues to defy man’s attempt to con-
trol it. Gonococcal infections and their complication are 
amongst the most frequent communicable diseases in 
many countries [1].
Gonococci have been adept at developing resistance to 
commonly used antimicrobials. Failure to cure a case of 
gonorrhoea has a public health implication, due to the po-
tential for continued transmission and rapid emergence 
of antimicrobial resistance. The present study was done 
to determine the prevalence of Neisseria gonorrhoeae, 
the antibiotics susceptibility pattern and to establish the 
most affected age groups. Despite a sharp decline in the 
incidence of gonococcal infection in developed coun-
tries during the last decade, gonorrhoea still remains one 
of the most common STIs in developing countries and a 
global health problem [2]. The prevalence of gonococ-
cal infection varies greatly among countries in the devel-
oped and developing world, the highest being in South 
and Southeast Asia, followed by sub-saharan Africa and 
Latin America where it continues to be a major public 
health problem. According to the World Health Organi-
zation, there are approximately 62 million new cases of 
gonorrhoea worldwide annually, and almost half of the 
cases are estimated to occur in Southeast Asia [1]. 
In the absence of any effective vaccine against N. gonor-
rhoeae, control of gonococcal infection mainly depends 
on safe sex practices and the identification and treat-
ment of infected individuals. An early and successful 
anti-biotic treatment of gonococcal infection or cures of 
the individual patient is important in prevention of com-
plications, and reduction  of transmission [3]. Strategies 
for the control of gonorrhoea have relied on the use of 
highly-effective and often single-dose therapy adminis-
tered at the time of diagnosis [4]. Information on anti-
microbial susceptibility of N. gonorrhoeae is therefore, 
important for the selection of an appropriate antimicro-
bial agent. 
The versatile nature of the gonococcus and its capacity 
to cope with changing conditions in micro-environment 
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is a major challenge in the prevention and control of 
gonococcal infection [5]. The continuous emergence of 
resistance to antimicrobial agents has made the treat-
ment of gonorrhoea expensive, prolonged, and unpre-
dictable. The organism acquires resistance by spontane-
ous mutation or by acquisition of new DNA via conju-
gation or transformation, and resistance may, thus, be 
chromosomal or plasmid-mediated. A single organism 
can have both the mechanisms of resistance, and resist-
ance to multiple antibiotics is often common [6]. 
Antimicrobial resistance in gonococci often spreads rap-
idly among countries, and infected travellers often ap-
pear for treatment in countries distant from the source 
of infection. Hence, data on local and regional antimi-
crobial resistance are important for the management and 
treatment of gonorrhoea.
Materials and methods
A total of 640 consecutive patients who attended the 
Outpatient Department (OPD) Clinics at St. Mary’s 
Hospital Lacor from Jan 2007-Dec 2011 with suspected 
gonorrhea and had urethral / high vagina swabs (HVS) 
discharge specimens taken, were included in the study. 
Data on the patients was retrieved from the culture 
record book.
A presumptive diagnosis of gonococcal infection 
was made observing polymorphonuclear leucocytes 
(PMNLs) with gram negative intra or extracellular 
diplococci (ICDC /ECDC). If the smear showed four or 
more PMNLs with the absence of gram negative ICDC / 
ECDC a presumptive diagnosis of non gonococcal ure-
thritis (NGU) was made.
The urethral /HVS discharge was plated onto Chocolate 
agar, incubated for 24 to 48hrs at 37°C in a 5% CO2 atmos-
phere. N. gonorrhoeae isolates were identified by colony 
morphology, a positive oxidase test, a Gram stain smear 
with gram-negative diplococci and rapid carbohydrate uti-
lisation. Antimicrobial susceptibility testing was performed 
and defined by the disk diffusion test (Kirby Bauer) as rec-
ommended by the Clinical and Laboratory Standards Insti-
tute (CLSI). Resistance profiles of all the N. gonorrhoeae 
isolates to seven antimicrobial agents (Ampicillin, cefotax-
ime, ceftriaxone,tetracycline, ciprofloxacin, Erythromycin 
and Gentamicin) were tested for by the disk diffusion test.
Results
Out of the 640 patients whose urethral swabs and HVS 
were cultured, 256 positive cultures (40%) out of which 
151 (59%) were found to have gonococcal infection, 
105 (41%) patients had other micro-organisms and 384 
(60%) had no bacterial growth and contaminants (uni-
dentified staphylococcus). 
In the Table I above, a number of organisms were 
isolated with the most frequent being Neisseria gon-
orrhoeae, and K.pneumoniae, Streptococcus and Es-
cherichia coli respectively and followed by staphylo-
coccus aureus and Proteus mirabilis with the least be-
ing enterobacter spp 1.
In Figure 1 above, isolates were more resistant to ampi-
cillin 23.4%, Ciprofloxacin 23.3%, Tetracycline 17.2% 
and Erythromycin 17.2%. Antibiotics to which there 
were less resistance included Cefotaxime 1.8% (0-1.5 
%), and Gentamicin 6.3% (5-25%) while intermediate 
resistance was seen with chloramphenicol 15.6%. 
While most of the resistances were relatively stable in 
the 5 years considered resistance to ciprofloxacine was 
constantly growing.
Discussion
Gonorrhoea is one of the most common sexually trans-
mitted infections (STIs) in developing countries, and the 
emergence of resistance to antimicrobial agents in Neis-
seria gonorrhoeae is a major obstacle in the control of 
gonorrhoea. Periodical monitoring of antimicrobial sus-
ceptibility of N. gonorrhoeae is essential for the early 
detection of emergence of drug resistance.
The control of gonococcal infection is important consid-
ering the high incidence of acute infections, complica-
tions, and sequelae and its role in facilitating acquisition 
and transmission of HIV [7]. The knowledge of antimi-
crobial susceptibility of N. gonorrhoeae is a prerequisite 
for the proper treatment and control of gonococcal infec-
tion. A regional programme for monitoring gonococcal 
antimicrobial susceptibility has been established in de-
veloped countries, such as the USA, Canada, Australia, 
and the Netherlands. However, in developing countries 
where the burden of disease is high and the resistances 
the greatest, such activity rarely exists.
A high prevalence of plasmid mediated high-level or 
chromosomally mediated low-level resistance to peni-
cillin or tetracycline has been reported in southeast 
Asia [8] and in African countries [9]. 
The currently recommended main treatments for gonorrhea 
are ceftriaxone, and ciprofloxacin. None of these agents are 
inexpensive. To ensure that limited resources are used in 
Tab. I. Showing the different organisms isolated from the urethral / 
hvS between Jan 2007-dec 2011.
Organisms Frequencies 
(N = 256)
Percentages 
(%)
K. pneumoniae 25 9.7
pseudomonas 3 1.2
Citrobacter 3 1.2
N.gonorrhoeae 151 59
Streptococcus 25 9.7
proteus mirabilis 8 3.1
Staphylococcus aureus 8 3.1
escherichia Coli 25 9.7
Salmonella spp 02 0.7
enterococcus spp 05 2.0
enterobacter spp 01 0.4
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the best possible way, continuous surveillance of gonococ-
cal resistance to these drugs is critically important.
The results of this study demonstrated that of the 640 
consecutive patients considered, 151(59%) were found 
to be having gonococcal urethritis. Gonococcal urethri-
tis was found more in males’ patients and less in the fe-
males, this is because females are mainly asymptomatic 
carriers and takes longer period of time for the signs and 
symptoms to show up.
Further, on the antibiotic sensitivity pattern, the study 
also demonstrated that there was significantly reduced 
sensitivity to ampicillin 23.4%, Ciprofloxacin 23.3%, 
Tetracycline 17.2% and Erythromycin 17.2%. 
Antibiotics to which there were less resistance includ-
ed Cefotaxime 1.8% (0-2.5 %), and Gentamicin 6.3% 
(5-25%) while intermediate resistance was seen with 
chloramphenicol 15.6%. This finding is consistent with 
a study by Monir et al. (2010) where they discovered 
that isolates were more resistant to penicillins, fluoro-
quinolones and tetracycline but all the isolates were sen-
sitive to cephalosporin and macrolides. 
The reasons for this outbreak of Neisseria gonorrhoeae 
strains with reduced sensitivity to Tetracycline, Ampi-
cillin and Ciprofloxacin could be due to increasing mis-
use of the antibiotics (drugs over the counter) as the 
empirical first-line treatment for Neisseria gonorrhoeae 
for the last several years, and also re-infection due to 
the presence of a large reservoir of asymptomatic car-
riers that unknowingly transmit the disease to their sex-
ual contacts since most women are not by their spouses 
when they are on treatment. 
Because of the high prevalence of Neisseria gonorrhoeae 
isolates with low susceptibility to tetracycline, ampicil-
lin, erythromycin and ciprofloxacin, it seems that single-
dose treatment with these agents may be problematic as 
first-line therapy for gonorrhoea in this district /country. 
Therefore, the antimicrobial sensitivity of Neisseria gon-
orrhoeae to Cefotaxime, gentamicin and the therapeutic 
efficacy of these antibiotics should be closely monitored.
Although the isolates were resistant to Tetracycline, 
Ampicillin, Erythromycin, and Ciprofloxacin and inter-
mediate to Chloramphenicol they were also sensitive to 
a panel of antibiotics such as Gentamicin (93.7%) and 
Cefotaxime (98.2%), therefore this can still assist in sin-
gle dose management of N. gonorrhoeae. 
Conclusion
Gonorrhoea is one of the old but re-emerging diseases in 
developing countries.
The prevalence of Neisseria gonorrhoeae in patient attend-
ing St. Mary’s Hospital Lacor-Gulu general out-patient was 
at 59%, and all of these had symptoms of pus discharges 
and frequency suggesting gonococcal urethritis.
The most common pathogen isolated was Neisseria gon-
orrhoeae (59%), followed by Klebsiella pneumoniae, 
Streptococcus, Escherichia coli (9.7%) respectively, sta-
phylococcus aureus and Proteus mirabilis with the least 
being enterobacter spp (0.4%).
The N. gonorrhoeae isolates were sensitive to Cefo-
taxime (98.2%) and Gentamicin (93.7%) and were in-
termediate to Chloramphenicol (15.2%), but these same 
isolates were also resistant to a panel of antibiotics like 
Ampicillin (23.4), Ciprofloxacin (23.3%), Erythromy-
cin (17.2%) and Tetracycline (17.2%). This therefore 
calls for sensitization on drug use.
The high rate of resistance to panel of antibiotics like 
Ampicillin, ciprofloxacin, Tetracycline and erythromy-
cin may preclude the use of these antibiotics as the em-
piric treatment of Neisseria gonorrhoeae in the region 
of north Uganda.
Fig. 1. Showing trend of isolates resistance to antibiotics used in lacor hospital, gulu between 2007 and 2011.
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